Skinvisible, Inc. (SKVI)

Market Cap	2.93M
Revenue (ttm)	20.00K
Net Income (ttm)	-1.19M
Shares Out	4.89M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	240
Open	0.566
Previous Close	0.566
Day's Range	0.566 - 0.600
52-Week Range	0.055 - 0.850
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 15, 2024

About Skinvisible

Skinvisible, Inc., together with its subsidiaries, focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women’s health, pain management, and other markets. The company’s flagship product is Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically appl...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1998
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: SKVI

Financial Performance

In 2023, Skinvisible's revenue was $20,000, a decrease of -92.84% compared to the previous year's $279,296. Losses were -$2.38 million, 94.5% more than in 2022.